X-129790968-C-G
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM1PM2BP4
The NM_018990.4(SASH3):c.329C>G(p.Ser110Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018990.4 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 102Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- combined immunodeficiency, X-linkedInheritance: XL Classification: STRONG Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Immunodeficiency 102 Uncertain:1
SASH3(NM_018990.4):c.329C>G (p.Ser110Cys) This is a missense variant that results in an amino acid substitution. This variant has not been observed in control samples or in patients with Immunodeficiency 102 (OMIM: 301082), fulfilling the PM2 criterion. Additionally, the description of the proband is very similar to clinical cases described, hence the PP4 criterion applies. Based on the applied ACMG/AMP criteria (PM2, PP4), this variant is classified as a Variant of Uncertain Significance (VUS) Immunodeficiency 102 (OMIM: 301082) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at